1,485 results on '"Frank, Igor"'
Search Results
2. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?
3. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
4. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy
5. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series
6. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy
7. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy
8. The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic Outcomes
9. Intraoperative Ventilatory Pressures During Robotic Assisted vs Open Radical Cystectomy
10. Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer.
11. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer
12. PD17-12 IS THERE A ROLE FOR C-11 PET-CT IN MEN WITH BIOCHEMICAL PROGRESSION OF PROSTATE CANCER AND NEGATIVE PSMA PET-CT?
13. PD34-06 CHANGES IN BODY COMPOSITION FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY
14. PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL
15. MP12-16 NATIONAL TRENDS IN SAME DAY DISCHARGE FOR RADICAL PROSTATECTOMY: AN EVOLUTION IN PRACTICE PATTERNS
16. MP77-18 PREDICTORS OF PELVIC RECURRENCE AFTER RADICAL CYSTECTOMY: IDENTIFYING THE IDEAL CANDIDATE FOR ADJUVANT RADIATION CLINICAL TRIALS
17. MP07-04 INITIAL EXPERIENCE WITH A FULLY INTEGRATED ARTIFICIAL INTELLIGENCE PLATFORM DURING MINIMALLY INVASIVE SURGERY
18. MP24-15 COMPARING FRAILTY INDICES FOR RISK STRATIFICATION IN UROLOGIC SURGERY: WHICH INDEX TO CHOOSE?
19. MP47-08 IMPACT OF HYPOGONADISM ON RADICAL CYSTECTOMY OUTCOMES
20. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications?
21. Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study
22. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV
23. Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection
24. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies
25. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy
26. IMPACT OF PROSTATE SIZE ON THE OUTCOMES OF RADICAL PROSTATECTOMY
27. VALUE OF B7-H3 EXPRESSION AS A PREDICTOR OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN UROTHELIAL CELL CARCINOMA OF BLADDER
28. Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy
29. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes
30. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
31. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma
32. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence
33. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy
34. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation
35. The Association of Aspirin Use with Survival Following Radical Cystectomy
36. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
37. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy
38. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
39. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy
40. Utilization and Outcomes of Radical Cystectomy for High-grade Non–muscle-invasive Bladder Cancer in Elderly Patients
41. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy
42. Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
43. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease
44. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients with Variant Histology Undergoing Radical Cystectomy
45. Relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy
46. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification
47. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin
48. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration
49. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
50. Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.